Literature DB >> 7800368

The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study.

I Dielemans1, J R Vingerling, R C Wolfs, A Hofman, D E Grobbee, P T de Jong.   

Abstract

PURPOSE: The objective of this study is to assess the prevalence of primary open-angle glaucoma (POAG) in a defined population in Rotterdam, The Netherlands.
METHODS: The Rotterdam Study is a single-center prospective cohort study of a total population of more than 10,000 people, 55 years of age or older. For the current analysis, the first 3062 consecutive, unselected, noninstitutionalized participants were examined according to standard protocols, including perimetry. The diagnosis of POAG was based on the presence of a glaucomatous visual field defect combined with either a vertical cup: disc ratio of 0.5 or more or a cup:disc ratio asymmetry of 0.2 or more, or an intraocular pressure (IOP) more than 21 mmHg, with open and normal anterior chamber angles.
RESULTS: The overall prevalence of POAG in the current study was 1.10% (95% confidence interval [CI]: 1.09, 1.11). Age-specific prevalence figures increased from 0.2% (95% CI: 0.16, 0.24) in the age group of 55 to 59 years to 3.3% (95% CI: 2.57, 4.04) in the age group of 85 to 89 years. Men had a more than three times higher risk of having POAG than women (odds ratio, 3.6). In 52.9% of the patients, POAG had not been diagnosed previously. Of these patients, 38.9% had IOPs of 21 mmHg or lower. In 8.8% of the eyes (2.9% of patients), visual acuity was 20/200 or less due to POAG.
CONCLUSION: The overall prevalence of POAG in the current study was 1.1%. The prevalence of POAG was higher in men than in women. Of the untreated patients, 38.9% had IOPs of 21 mmHg or lower.

Entities:  

Mesh:

Year:  1994        PMID: 7800368     DOI: 10.1016/s0161-6420(94)31090-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  135 in total

1.  The effects of new topical treatments on management of glaucoma in Scotland: an examination of ophthalmological health care.

Authors:  D N Bateman; R Clark; A Azuara-Blanco; M Bain; J Forrest
Journal:  Br J Ophthalmol       Date:  2002-05       Impact factor: 4.638

2.  Glaucoma: our role in reducing the burden of blindness.

Authors:  Lenworth N Johnson
Journal:  J Natl Med Assoc       Date:  2002-10       Impact factor: 1.798

3.  Glaucoma surgery with or without adjunctive antiproliferatives in normal tension glaucoma: 1 intraocular pressure control and complications.

Authors:  W L Membrey; D P Poinoosawmy; C Bunce; R A Hitchings
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

4.  3D visualization of aqueous humor outflow structures in-situ in humans.

Authors:  Larry Kagemann; Gadi Wollstein; Hiroshi Ishikawa; Ian A Sigal; Lindsey S Folio; Juan Xu; Haiyan Gong; Joel S Schuman
Journal:  Exp Eye Res       Date:  2011-04-15       Impact factor: 3.467

5.  Prevalence of primary open angle glaucoma in general ophthalmic practice in the United Kingdom.

Authors:  M Kroese; H Burton; S Vardy; T Rimmer; D McCarter
Journal:  Br J Ophthalmol       Date:  2002-09       Impact factor: 4.638

Review 6.  Primary open angle glaucoma. The need for a consensus case definition.

Authors:  M Kroese; H Burton
Journal:  J Epidemiol Community Health       Date:  2003-09       Impact factor: 3.710

7.  Optic nerve head morphometry in healthy adults using confocal laser scanning tomography.

Authors:  M M Hermann; I Theofylaktopoulos; N Bangard; C Jonescu-Cuypers; S Coburger; M Diestelhorst
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

8.  Dorsomedial/Perifornical hypothalamic stimulation increases intraocular pressure, intracranial pressure, and the translaminar pressure gradient.

Authors:  Brian C Samuels; Nathan M Hammes; Philip L Johnson; Anantha Shekhar; Stuart J McKinnon; R Rand Allingham
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-23       Impact factor: 4.799

9.  The utilization of eye care services by persons with glaucoma in rural south India.

Authors:  Alan L Robin; Praveen K Nirmalan; Ramasamy Krishnadas; Rengappa Ramakrishnan; Joanne Katz; James Tielsch; Ravilla D Thulasiraj; David S Friedman
Journal:  Trans Am Ophthalmol Soc       Date:  2004

10.  Differential up-regulation of Vesl-1/Homer 1 protein isoforms associated with decline in visual performance in a preclinical glaucoma model.

Authors:  Simon Kaja; Yuliya Naumchuk; Stephanie L Grillo; Priscilla K Borden; Peter Koulen
Journal:  Vision Res       Date:  2013-11-09       Impact factor: 1.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.